A1BDS

N~1~-{5-[(N-{4-[(3-aminopropyl)amino]butyl}-beta-alanyl)amino]pentyl}-N~2~-[(1H-indol-3-yl)acetyl]-D-aspartamide

Created:	2024-10-15
Last modified:	2024-12-11

Find Related PDB Entry
1 entries where A1BDS is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	89
Chiral Atom Count	1
Bond Count	90
Aromatic Bond Count	10

2D diagram of A1BDS

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N~1~-{5-[(N-{4-[(3-aminopropyl)amino]butyl}-beta-alanyl)amino]pentyl}-N~2~-[(1H-indol-3-yl)acetyl]-D-aspartamide
Systematic Name (OpenEye OEToolkits)	(2~{R})-~{N}-[5-[3-[4-(3-azanylpropylamino)butylamino]propanoylamino]pentyl]-2-[2-(1~{H}-indol-3-yl)ethanoylamino]butanediamide
Formula	C₂₉ H₄₈ N₈ O₄
Molecular Weight	572.743
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	14.52	NCCCNCCCCNCCC(=O)NCCCCCNC(=O)C(CC(N)=O)NC(=O)Cc1c[NH]c2ccccc21
SMILES	CACTVS	3.385	NCCCNCCCCNCCC(=O)NCCCCCNC(=O)[CH](CC(N)=O)NC(=O)Cc1c[nH]c2ccccc12
SMILES	OpenEye OEToolkits	3.1.0.0	c1ccc2c(c1)c(c[nH]2)CC(=O)NC(CC(=O)N)C(=O)NCCCCCNC(=O)CCNCCCCNCCCN
Canonical SMILES	CACTVS	3.385	NCCCNCCCCNCCC(=O)NCCCCCNC(=O)[C@@H](CC(N)=O)NC(=O)Cc1c[nH]c2ccccc12
Canonical SMILES	OpenEye OEToolkits	3.1.0.0	c1ccc2c(c1)c(c[nH]2)CC(=O)N[C@H](CC(=O)N)C(=O)NCCCCCNC(=O)CCNCCCCNCCCN
InChI	InChI	1.06	InChI=1S/C29H48N8O4/c30-12-8-15-32-13-6-7-14-33-18-11-27(39)34-16-4-1-5-17-35-29(41)25(20-26(31)38)37-28(40)19-22-21-36-24-10-3-2-9-23(22)24/h2-3,9-10,21,25,32-33,36H,1,4-8,11-20,30H2,(H2,31,38)(H,34,39)(H,35,41)(H,37,40)/t25-/m1/s1
InChIKey	InChI	1.06	ILUCYJIKJBTHOD-RUZDIDTESA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.